P070 <break /> Long-term efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): results from the TOMORROW trial and its open-label extension

Authors :: Katell Bernois
Moisés Selman
Ulrich Costabel
Luca Richeldi
Manuel Quaresma
Wim A. Wuyts
Anne-Marie Kirsten
Susanne Stowasser
Source :: QJM: An International Journal of Medicine.
Publication Year :: 2016
Publisher :: Oxford University Press (OUP), 2016.

Subjects :: medicine.medical_specialty
business.industry
General Medicine
medicine.disease
Surgery
Term (time)
03 medical and health sciences
Idiopathic pulmonary fibrosis
chemistry.chemical_compound
0302 clinical medicine
chemistry
Internal medicine
medicine
Nintedanib
In patient
030212 general & internal medicine
Open label
business

Tools